Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Depreciation & Amortization (CF) (2021 - 2025)

Medicinova (MNOV) has disclosed Depreciation & Amortization (CF) for 8 consecutive years, with $4199.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) changed N/A to $4199.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9376.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $20099.0 for FY2025, 4.64% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $4199.0 at Medicinova, down from $5177.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $7168.0 in Q3 2021, with the low at $4105.0 in Q1 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $5439.2, with a median of $5360.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) tumbled 31.37% in 2022, then soared 30.33% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $6374.0 in 2021, then crashed by 30.51% to $4429.0 in 2022, then grew by 24.0% to $5492.0 in 2023, then fell by 5.68% to $5180.0 in 2024, then fell by 18.94% to $4199.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $4199.0, $5177.0, and $5180.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.